Attovia Therapeutics (ATTO) vs SL Science (SLBT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
SL Science is the larger company by market cap ($846.7 million vs $715.1 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATTO | SLBT |
|---|---|---|
| Share price | $15.67 | $1.51 |
| Market cap | $715.13M | $846.75M |
| 1-day change | -4.61% | 0.00% |
| YTD return | — | -85.68% |
| 1-year return | — | -85.42% |
| EPS (TTM) | $-2.74 | $-0.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $28.00 | $14.50 |
| 52-week low | $15.62 | $1.42 |
| Distance from 52-week high | -44.05% | -89.59% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +169.39% | — |
| Average volume | 458.24K | 80.93K |
| Shares outstanding | 45.65M | 560.76M |
| Employees | 44 | 14 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Attovia Therapeutics
ATTO stock →Attovia Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops biotherapeutics for immune-mediated diseases in the United States. The company provides ATTOBODY, a biparatopic biologics platform designed to deliver improved treatments.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 44 employees
About SL Science
SLBT stock →SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 14 employees
ATTO vs SLBT FAQ
Which is bigger, Attovia Therapeutics or SL Science?
SL Science (SLBT) is larger, with a market capitalization of $846.75M compared with $715.13M for Attovia Therapeutics (ATTO).
Are Attovia Therapeutics and SL Science in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.